SlideShare a Scribd company logo
Labelling Assessment
Unexpected adverse reaction
 ICH definition: An “unexpected” adverse reaction is the
one, the nature or severity of which is not consistent with
the applicable product information (Reference safety
information (RSI)).
 Various RSI include:
1. CCDS: company core data sheet
2. USPI: United states product information
3. SPC: summary of product characteristics
4. PM: product monograph
5. IB: Investigator’s brochure
Unexpected adverse reaction
 FDA definition (21CFR314.80): Any adverse drug experience
that is not listed in the current labeling for the drug
product.
 This includes events that may be symptomatically and
pathophysiologically related to an event listed in the
labeling, but differ from the event because of greater
severity or specificity.
Expectedness assessment is done
at two levels
 Event level: each event will be assessed individually.
 Case level: overall expectedness. If one or more events is
deemed unexpected, the case will be assessed as
“unexpected”. The case level assessment will determine
regulatory reporting.
Which RSI to refer to?
 Postmarketing (NDA): CCDS (Core)
SPC,PM or USPI (local)
 Premarketing(IND): IB.
Expectedness and specificity
An event more specific than described
in the RSI would be considered
“unexpected”.
Example: If retinopathy is in the label, and now you see a case of
diabetic retinopathy, which is not in the label—the event would be
considered unexpected.
Expectedness and severity
An event more severe than described
in the RSI would be considered
“unexpected”.
Example: Circulatory collapse is considered unexpected when
hypotension is labelled.
Expectedness and seriousness
 An event more serious than described in the RSI would be
considered “unexpected”.
Example: ‘Hepatitis’ is listed in the RSI, but the reported event is
‘fulminant hepatitis’ then it becomes unexpected.
Expectedness & additional
signs & symptoms
 If a diagnosis is listed in the RSI as an ‘expected’ adverse
reaction, the signs and symptoms that comprise the
diagnosis are also ‘expected’.
 The signs and symptoms need not be specifically listed.
 However, if one or more reported events are not a
recognized sign or symptom of the diagnosis, these events
would be classified as unexpected’.
Continued……
• Example: If anaphylactic reaction is labelled, then a report of a
patient who experienced hypotension, wheezing, and urticaria
together would be considered as an expected event.
Expectedness and fatal
outcomes
 Unless the RSI specifies a fatal outcome, the case should be
considered as ‘unexpected’ as long as there is an
association between the AE and the fatality.
Example: Agranulocytosis is listed in the RSI. A report is
received of a patient who developed fatal agranulocytosis.
Agranulocytosis would be considered ‘unexpected’ in this
instance.
Expectedness and LOE
 Lack of efficacy (LOE) – Is an ‘expected’ event.
 However this may not be a case in cases where the
indication is a life threatening condition.
Expectedness and medication
error
 ‘Medications error’ as an event is assessed generally as
unexpected.
Expectedness and PQI
 Product quality issue (PQI) – is an expected event.
Example: In case there is any problem with the bottle
opening, taste or odor of the product, any formulation
problem then it is considered as a PQI.
Expectedness in pregnancy
cases
* ‘Pregnancy’ as an event is unassessable: hence the labels
will be NA (Not applicable).
* Any event along with pregnancy will be assessed as per the
normal labeling guidelines.
Expectedness and overdose
 If in an overdose case the AE is listed in the ‘adverse
events/reactions’ or ‘undesirable events/reactions’ or
‘overdose section’ then it is expected in overdose case also.
 However if the event is listed under ‘overdose’ section of RSI
and the case is not an overdose case then the event is
unexpected.
Expectedness and drug
interaction
* Expectedness in case of drug interactions will be considered
based on individual drug interactions and the class effect
should not be considered.
Example: Events are listed under drug interaction of
alprazolam and microlides, but the reported event has
occurred in a patient with alprazolam and azithromycin
interaction then it will be considered unexpected.
Expectedness and cross LLT’s
 If two different event are having the same PT then if either
of them is mentioned in the RSI the other becomes
expected.
i.e:
 If event ‘A’ and ‘B’ have the same PT say ‘C’. Then if in the
RSI event ‘A’ is listed but event ‘B’ is unlisted then 'B’ also
becomes expected.
 Check for different spelling:
E.g.:
1. Anaemia – anemia
2. Diarrhoea – diarrhea
3. Oedema – edema
4. Colour – color
Hence try to search with common letters.
e.g.: search with ‘emia’, ‘diarr’, ‘edema’ and ‘col’ respectively.
Quiz ?
 1. Example:
The prescribing information lists “hives,
hypotension, wheezing, and angioedema”
A patient is reported to have experienced
anaphylaxis.
Would you consider anaphylaxis as an
expected event?
 Answer:
 No
 Guideline:
 An adverse event must be expressly
mentioned for it to be considered
“expected”
Example:
“Pneumonia” is listed in the prescribing
information and a patient’s x-ray shows
pulmonary infiltrates
Would you consider pulmonary infiltrates
expected?
Answer:
No
Guideline:
 Pulmonary infiltrates should not be
considered “expected” as this could be
indicative of other diagnoses
labelling.pptx

More Related Content

Similar to labelling.pptx

adverse drug reactions management
adverse drug reactions  managementadverse drug reactions  management
adverse drug reactions management
pharmacologyseminars
 
ICH - E2D Pharmacovigilance and Drug Safety - Professor Peivand Pirouzi
ICH - E2D Pharmacovigilance and Drug Safety - Professor Peivand PirouziICH - E2D Pharmacovigilance and Drug Safety - Professor Peivand Pirouzi
ICH - E2D Pharmacovigilance and Drug Safety - Professor Peivand Pirouzi
Pharmaceutical Compliance Inspection unit, Crown College of Canada
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
Gaurav kumar
 
Adverse Drug Reactions.pptx
Adverse Drug Reactions.pptxAdverse Drug Reactions.pptx
Adverse Drug Reactions.pptx
AjithJs2
 
Pharmacovigilance by khaga
Pharmacovigilance by khagaPharmacovigilance by khaga
Pharmacovigilance by khaga
Khadga Raj
 
Pharmacovigilance suresh
Pharmacovigilance  sureshPharmacovigilance  suresh
Pharmacovigilance suresh
sri indu institute of pharmacy
 
What to Do When There Are Adverse Events and Serious Adverse Events
What to Do When There Are Adverse Events and Serious Adverse EventsWhat to Do When There Are Adverse Events and Serious Adverse Events
What to Do When There Are Adverse Events and Serious Adverse Events
TrialJoin
 
Causality assessment scales
Causality assessment scalesCausality assessment scales
Causality assessment scales
Dr Renju Ravi
 
Www
WwwWww
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
Vladimir Patras
 
Adverse Event Reporting in Pharmacovigilance: Principles and Challenges
Adverse Event Reporting in Pharmacovigilance: Principles and ChallengesAdverse Event Reporting in Pharmacovigilance: Principles and Challenges
Adverse Event Reporting in Pharmacovigilance: Principles and Challenges
ClinosolIndia
 
PV-16_1_Guideline on good pharmacovigilance practices (GVP) (1).pptx
PV-16_1_Guideline on good pharmacovigilance practices (GVP) (1).pptxPV-16_1_Guideline on good pharmacovigilance practices (GVP) (1).pptx
PV-16_1_Guideline on good pharmacovigilance practices (GVP) (1).pptx
Paramita Saha
 
pharmacovigilance-training Pharmacovigilance in INDIA.pptx
pharmacovigilance-training Pharmacovigilance in INDIA.pptxpharmacovigilance-training Pharmacovigilance in INDIA.pptx
pharmacovigilance-training Pharmacovigilance in INDIA.pptx
MrSALAJKHARE
 
pharmacovigilance-training (1).pptx
pharmacovigilance-training (1).pptxpharmacovigilance-training (1).pptx
pharmacovigilance-training (1).pptx
biruktesfaye27
 
DRUG SAFETY REPORTING.pptx
DRUG SAFETY REPORTING.pptxDRUG SAFETY REPORTING.pptx
DRUG SAFETY REPORTING.pptx
Ameena Kadar
 
Expectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLSExpectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLS
Katalyst HLS
 
Nombre de décès estimés du fait du vaccin aux USA
Nombre de décès estimés du fait du vaccin aux USANombre de décès estimés du fait du vaccin aux USA
Nombre de décès estimés du fait du vaccin aux USA
Société Tripalio
 
PvPI ADR reporting communication under pvpi
PvPI ADR reporting  communication under pvpiPvPI ADR reporting  communication under pvpi
PvPI ADR reporting communication under pvpi
chshubham03
 
Adverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingAdverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & Reporting
Ruella D'Costa Fernandes
 
SDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical EventsSDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical Events
Vijayaraghava Karpurapu
 

Similar to labelling.pptx (20)

adverse drug reactions management
adverse drug reactions  managementadverse drug reactions  management
adverse drug reactions management
 
ICH - E2D Pharmacovigilance and Drug Safety - Professor Peivand Pirouzi
ICH - E2D Pharmacovigilance and Drug Safety - Professor Peivand PirouziICH - E2D Pharmacovigilance and Drug Safety - Professor Peivand Pirouzi
ICH - E2D Pharmacovigilance and Drug Safety - Professor Peivand Pirouzi
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Adverse Drug Reactions.pptx
Adverse Drug Reactions.pptxAdverse Drug Reactions.pptx
Adverse Drug Reactions.pptx
 
Pharmacovigilance by khaga
Pharmacovigilance by khagaPharmacovigilance by khaga
Pharmacovigilance by khaga
 
Pharmacovigilance suresh
Pharmacovigilance  sureshPharmacovigilance  suresh
Pharmacovigilance suresh
 
What to Do When There Are Adverse Events and Serious Adverse Events
What to Do When There Are Adverse Events and Serious Adverse EventsWhat to Do When There Are Adverse Events and Serious Adverse Events
What to Do When There Are Adverse Events and Serious Adverse Events
 
Causality assessment scales
Causality assessment scalesCausality assessment scales
Causality assessment scales
 
Www
WwwWww
Www
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Adverse Event Reporting in Pharmacovigilance: Principles and Challenges
Adverse Event Reporting in Pharmacovigilance: Principles and ChallengesAdverse Event Reporting in Pharmacovigilance: Principles and Challenges
Adverse Event Reporting in Pharmacovigilance: Principles and Challenges
 
PV-16_1_Guideline on good pharmacovigilance practices (GVP) (1).pptx
PV-16_1_Guideline on good pharmacovigilance practices (GVP) (1).pptxPV-16_1_Guideline on good pharmacovigilance practices (GVP) (1).pptx
PV-16_1_Guideline on good pharmacovigilance practices (GVP) (1).pptx
 
pharmacovigilance-training Pharmacovigilance in INDIA.pptx
pharmacovigilance-training Pharmacovigilance in INDIA.pptxpharmacovigilance-training Pharmacovigilance in INDIA.pptx
pharmacovigilance-training Pharmacovigilance in INDIA.pptx
 
pharmacovigilance-training (1).pptx
pharmacovigilance-training (1).pptxpharmacovigilance-training (1).pptx
pharmacovigilance-training (1).pptx
 
DRUG SAFETY REPORTING.pptx
DRUG SAFETY REPORTING.pptxDRUG SAFETY REPORTING.pptx
DRUG SAFETY REPORTING.pptx
 
Expectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLSExpectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLS
 
Nombre de décès estimés du fait du vaccin aux USA
Nombre de décès estimés du fait du vaccin aux USANombre de décès estimés du fait du vaccin aux USA
Nombre de décès estimés du fait du vaccin aux USA
 
PvPI ADR reporting communication under pvpi
PvPI ADR reporting  communication under pvpiPvPI ADR reporting  communication under pvpi
PvPI ADR reporting communication under pvpi
 
Adverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingAdverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & Reporting
 
SDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical EventsSDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical Events
 

Recently uploaded

BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
Nguyen Thanh Tu Collection
 
Life upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for studentLife upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for student
NgcHiNguyn25
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
National Information Standards Organization (NISO)
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
PECB
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
Celine George
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Akanksha trivedi rama nursing college kanpur.
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
Academy of Science of South Africa
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
History of Stoke Newington
 
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 InventoryHow to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
Celine George
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
mulvey2
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
TechSoup
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 
Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5
sayalidalavi006
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Fajar Baskoro
 
The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
heathfieldcps1
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
GeorgeMilliken2
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
adhitya5119
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
Colégio Santa Teresinha
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
Dr. Shivangi Singh Parihar
 

Recently uploaded (20)

BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
 
Life upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for studentLife upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for student
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
 
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 InventoryHow to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 
Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
 
The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
 

labelling.pptx

  • 2. Unexpected adverse reaction  ICH definition: An “unexpected” adverse reaction is the one, the nature or severity of which is not consistent with the applicable product information (Reference safety information (RSI)).  Various RSI include: 1. CCDS: company core data sheet 2. USPI: United states product information 3. SPC: summary of product characteristics 4. PM: product monograph 5. IB: Investigator’s brochure
  • 3. Unexpected adverse reaction  FDA definition (21CFR314.80): Any adverse drug experience that is not listed in the current labeling for the drug product.  This includes events that may be symptomatically and pathophysiologically related to an event listed in the labeling, but differ from the event because of greater severity or specificity.
  • 4. Expectedness assessment is done at two levels  Event level: each event will be assessed individually.  Case level: overall expectedness. If one or more events is deemed unexpected, the case will be assessed as “unexpected”. The case level assessment will determine regulatory reporting.
  • 5. Which RSI to refer to?  Postmarketing (NDA): CCDS (Core) SPC,PM or USPI (local)  Premarketing(IND): IB.
  • 6. Expectedness and specificity An event more specific than described in the RSI would be considered “unexpected”. Example: If retinopathy is in the label, and now you see a case of diabetic retinopathy, which is not in the label—the event would be considered unexpected.
  • 7. Expectedness and severity An event more severe than described in the RSI would be considered “unexpected”. Example: Circulatory collapse is considered unexpected when hypotension is labelled.
  • 8. Expectedness and seriousness  An event more serious than described in the RSI would be considered “unexpected”. Example: ‘Hepatitis’ is listed in the RSI, but the reported event is ‘fulminant hepatitis’ then it becomes unexpected.
  • 9. Expectedness & additional signs & symptoms  If a diagnosis is listed in the RSI as an ‘expected’ adverse reaction, the signs and symptoms that comprise the diagnosis are also ‘expected’.  The signs and symptoms need not be specifically listed.  However, if one or more reported events are not a recognized sign or symptom of the diagnosis, these events would be classified as unexpected’.
  • 10. Continued…… • Example: If anaphylactic reaction is labelled, then a report of a patient who experienced hypotension, wheezing, and urticaria together would be considered as an expected event.
  • 11. Expectedness and fatal outcomes  Unless the RSI specifies a fatal outcome, the case should be considered as ‘unexpected’ as long as there is an association between the AE and the fatality. Example: Agranulocytosis is listed in the RSI. A report is received of a patient who developed fatal agranulocytosis. Agranulocytosis would be considered ‘unexpected’ in this instance.
  • 12. Expectedness and LOE  Lack of efficacy (LOE) – Is an ‘expected’ event.  However this may not be a case in cases where the indication is a life threatening condition.
  • 13. Expectedness and medication error  ‘Medications error’ as an event is assessed generally as unexpected.
  • 14. Expectedness and PQI  Product quality issue (PQI) – is an expected event. Example: In case there is any problem with the bottle opening, taste or odor of the product, any formulation problem then it is considered as a PQI.
  • 15. Expectedness in pregnancy cases * ‘Pregnancy’ as an event is unassessable: hence the labels will be NA (Not applicable). * Any event along with pregnancy will be assessed as per the normal labeling guidelines.
  • 16. Expectedness and overdose  If in an overdose case the AE is listed in the ‘adverse events/reactions’ or ‘undesirable events/reactions’ or ‘overdose section’ then it is expected in overdose case also.  However if the event is listed under ‘overdose’ section of RSI and the case is not an overdose case then the event is unexpected.
  • 17. Expectedness and drug interaction * Expectedness in case of drug interactions will be considered based on individual drug interactions and the class effect should not be considered. Example: Events are listed under drug interaction of alprazolam and microlides, but the reported event has occurred in a patient with alprazolam and azithromycin interaction then it will be considered unexpected.
  • 18. Expectedness and cross LLT’s  If two different event are having the same PT then if either of them is mentioned in the RSI the other becomes expected. i.e:  If event ‘A’ and ‘B’ have the same PT say ‘C’. Then if in the RSI event ‘A’ is listed but event ‘B’ is unlisted then 'B’ also becomes expected.
  • 19.  Check for different spelling: E.g.: 1. Anaemia – anemia 2. Diarrhoea – diarrhea 3. Oedema – edema 4. Colour – color Hence try to search with common letters. e.g.: search with ‘emia’, ‘diarr’, ‘edema’ and ‘col’ respectively.
  • 20. Quiz ?  1. Example: The prescribing information lists “hives, hypotension, wheezing, and angioedema” A patient is reported to have experienced anaphylaxis. Would you consider anaphylaxis as an expected event?
  • 21.  Answer:  No  Guideline:  An adverse event must be expressly mentioned for it to be considered “expected”
  • 22. Example: “Pneumonia” is listed in the prescribing information and a patient’s x-ray shows pulmonary infiltrates Would you consider pulmonary infiltrates expected?
  • 23. Answer: No Guideline:  Pulmonary infiltrates should not be considered “expected” as this could be indicative of other diagnoses